These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25881899)

  • 1. The potential role of IL-33/ST2 signaling in fibrotic diseases.
    Gao Q; Li Y; Li M
    J Leukoc Biol; 2015 Jul; 98(1):15-22. PubMed ID: 25881899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases.
    Xu D; Barbour M; Jiang HR; Mu R
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):141-146. PubMed ID: 31498062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
    Willems S; Hoefer I; Pasterkamp G
    Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-33/ST2 pathway: therapeutic target and novel biomarker.
    Kakkar R; Lee RT
    Nat Rev Drug Discov; 2008 Oct; 7(10):827-40. PubMed ID: 18827826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress on interleukin-33 and its roles in the central nervous system.
    Han P; Mi WL; Wang YQ
    Neurosci Bull; 2011 Oct; 27(5):351-7. PubMed ID: 21934731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KU812 cells provide a novel in vitro model of the human IL-33/ST2L axis: functional responses and identification of signaling pathways.
    Tare N; Li H; Morschauser A; Cote-Sierra J; Ju G; Renzetti L; Lin TA
    Exp Cell Res; 2010 Sep; 316(15):2527-37. PubMed ID: 20406635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ST2 transgenic mice with resistance to IL-33.
    Ohto-Ozaki H; Kuroiwa K; Mato N; Matsuyama Y; Hayakawa M; Tamemoto H; Tominaga S
    Eur J Immunol; 2010 Sep; 40(9):2632-42. PubMed ID: 20662097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
    Miller AM; Liew FY
    Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
    Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
    J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33, a novel member of the IL-1/IL-18 cytokine family, in cardiology and cardiac surgery.
    Kunes P; Holubcova Z; Kolackova M; Krejsek J
    Thorac Cardiovasc Surg; 2010 Dec; 58(8):443-9. PubMed ID: 21113894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin-33 in chronic allergic conjunctivitis.
    Matsuda A; Okayama Y; Terai N; Yokoi N; Ebihara N; Tanioka H; Kawasaki S; Inatomi T; Katoh N; Ueda E; Hamuro J; Murakami A; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4646-52. PubMed ID: 19458329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
    Schmieder A; Multhoff G; Radons J
    Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
    Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
    Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
    Zeng S; Wu J; Liu J; Qi F; Liu B
    Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma.
    Lee HY; Rhee CK; Kang JY; Byun JH; Choi JY; Kim SJ; Kim YK; Kwon SS; Lee SY
    Exp Lung Res; 2014 Mar; 40(2):66-76. PubMed ID: 24446582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of ST2: the International ST2 Consensus Panel.
    Pascual-Figal DA; Januzzi JL
    Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-33/ST2 axis: Role in health and disease.
    De la Fuente M; MacDonald TT; Hermoso MA
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
    Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
    Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.